ViaDerma (VDRM) Stock Price, News & Analysis

Company Overview

ViaDerma, Inc. (OTCMKTS: VDRM) is a dermatology-based healthcare company focused on the research, development and commercialization of proprietary topical skin-therapy products. Leveraging a patented elemental skin-therapy platform, the company designs formulations aimed at accelerating skin recovery, improving hydration and enhancing barrier function. Its product development process combines principles of biochemistry with clinical dermatology to address conditions ranging from dryness and irritation to minor wounds and abrasions.

The company’s flagship offerings include the Return2Life™ line of topical creams and lotions, which are formulated with a unique blend of essential minerals and electrolytes. These over-the-counter products are intended for immediate skin relief and longer-term restoration of the epidermal barrier. ViaDerma’s product portfolio is positioned to serve healthcare providers, first responders and retail consumers seeking scientifically driven skin-care solutions.

ViaDerma distributes its products primarily throughout the United States via multiple channels, including direct-to-consumer e-commerce platforms, partnerships with dermatology clinics and healthcare institutions, and select retail outlets. The company works closely with licensed practitioners and medical facilities to expand awareness of its formulations for use in both acute care settings and daily skin-care regimens.

Founded with the goal of translating cutting-edge skin-science into practical therapies, ViaDerma is led by a management team with backgrounds in pharmaceutical formulation, clinical research and dermatology. Headquartered in Florida, the company continues to advance its pipeline through ongoing R&D efforts, strategic collaborations and the pursuit of additional patent protections to support its long-term growth in the dermatological market.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.02
• Volume: 1,189 shs
• Average Volume: 1.16 million shs
• Market Capitalization: N/A
• P/E Ratio: 0.00
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VDRM Stock Analysis - Frequently Asked Questions

How have VDRM shares performed this year?

ViaDerma's stock was trading at $0.0074 at the beginning of the year. Since then, VDRM stock has decreased by 98.6% and is now trading at $0.0001.

How do I buy shares of ViaDerma?

Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ViaDerma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ViaDerma investors own include Tesla (TSLA), Dominari (DOMH), Co-Diagnostics (CODX), CEA Industries (CEAD), Organicell Regenerative Medicine (BPSR), AutoZone (AZO).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:VDRM
• CIK: N/A
• Web: viadermalicensing.com
• Phone: (310) 734-6111
• Fax: N/A
• Employees: 75
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A